Photovoltaic power modules for NASA's manned space station

The capability and the safety of manned spacecraft are largely dependent upon reliable electric power systems. Two similar space power systems able to survive the low Earth orbit environment, are being considered for NASA's Manned Space Station (SS), scheduled to begin operation in the mid 1990's. The Space Station Electric Power System (EPS) is composed of Photovoltaic (PV) Power Modules, Solar Dynamic (SD) Power Modules, and the Power Management and Distribution (PMAD) System. One EPS configuration will deliver 37.5 kW of PV based, utility grade, ac power to SS users. A second 75 kWe PV based EPS option is also being considered for SS deployment. The two EPS options utilize common modules and differ only in the total number of PV Power Modules used. Each PV Power Module supplies 18.75 kWe of ac power and incorporates its own energy storage and thermal control. The general requirements and the current preliminary design configuration of the Space Station PV Power Modules are examined

Space Station Photovoltaic Power Modules

Silicon cell Photovoltaic (PV) power modules are key components of the Space Station Electrical Power System (EPS) scheduled to begin deployment in 1994. Four PV power modules, providing 75 kWe of user ac power, form the cornerstone of the EPS; which is comprised of Photovoltaic (PV) power modules, Solar Dynamic (SD) power modules, and the Power Management and Distribution (PMAD) system. The PV modules are located on rotating outboard sections of the Space Station (SS) structure and each module incorporates its own nickel-hydrogen energy storage batteries, its own thermal control system, and some autonomous control features. The PV modules are a cost-effective and technologically mature approach for providing reliable SS electrical power and are a solid base for EPS growth, which is expected to reach 300 kWe by the end of the Space Station\u27s 30 year design lifetime

Personalized medicine in psychiatry: problems and promises

The central theme of personalized medicine is the premise that an individual’s unique physiologic characteristics play a significant role in both disease vulnerability and in response to specific therapies. The major goals of personalized medicine are therefore to predict an individual’s susceptibility to developing an illness, achieve accurate diagnosis, and optimize the most efficient and favorable response to treatment. The goal of achieving personalized medicine in psychiatry is a laudable one, because its attainment should be associated with a marked reduction in morbidity and mortality. In this review, we summarize an illustrative selection of studies that are laying the foundation towards personalizing medicine in major depressive disorder, bipolar disorder, and schizophrenia. In addition, we present emerging applications that are likely to advance personalized medicine in psychiatry, with an emphasis on novel biomarkers and neuroimaging